Twist Bioscience Corp. (TWST)
132.75
-11.74
(-8.13%)
USD |
NASDAQ |
Oct 16, 16:00
130.74
-2.01
(-1.51%)
After-Hours: 20:00
Twist Bioscience Cash from Investing (Quarterly) : -10.20M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.20M |
| March 31, 2026 | -12.71M |
| December 31, 2025 | -9.933M |
| September 30, 2025 | -12.40M |
| June 30, 2025 | -9.397M |
| March 31, 2025 | -1.426M |
| December 31, 2024 | -1.536M |
| September 30, 2024 | -1.285M |
| June 30, 2024 | -0.711M |
| March 31, 2024 | -5.24M |
| December 31, 2023 | 4.165M |
| September 30, 2023 | -2.247M |
| June 30, 2023 | 18.67M |
| March 31, 2023 | 41.16M |
| December 31, 2022 | -6.971M |
| September 30, 2022 | 2.783M |
| June 30, 2022 | 4.163M |
| March 31, 2022 | -13.29M |
| Date | Value |
|---|---|
| December 31, 2021 | -226.58M |
| September 30, 2021 | 23.91M |
| June 30, 2021 | 104.58M |
| March 31, 2021 | 73.59M |
| December 31, 2020 | -45.92M |
| September 30, 2020 | -94.67M |
| June 30, 2020 | -61.15M |
| March 31, 2020 | 28.76M |
| December 31, 2019 | 12.40M |
| September 30, 2019 | -1.187M |
| June 30, 2019 | -22.71M |
| March 31, 2019 | -15.16M |
| December 31, 2018 | -65.76M |
| September 30, 2018 | -0.03M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | -14.33M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -141.57M |
| Beam Therapeutics, Inc. | -9.875M |
| Prime Medicine, Inc. | 24.03M |
| Absci Corp. | 24.07M |
| 10X Genomics, Inc. | -7.735M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.115M |
| Cash from Financing (Quarterly) | 3.787M |
| Free Cash Flow | -93.22M |
| Free Cash Flow Per Share (Quarterly) | -0.1386 |
| Free Cash Flow to Equity (Quarterly) | -6.397M |
| Free Cash Flow to Firm (Quarterly) | -8.648M |
| Free Cash Flow Yield | -1.14% |